Armata Pharmaceuticals, Inc. Cash Flow Statement
ARMP|1 years of annual SEC 10-K data (FY2014-FY2014)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid. All figures from audited SEC 10-K filings.
Armata Pharmaceuticals, Inc. used $13M in operating cash flow and negative free cash flow of $14M in FY2014.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -12.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2014 |
|---|---|
| Net Income | $23.1M |
| Operating Cash Flow | -$12.6M |
| Capital Expenditures | $1.2M |
| Free Cash Flow | -$13.8M |
| FCF Margin | -3367.7% |